## Clinical Diagnosis & Interpretation This patient presents with **enteric fever in the third week of illness**, supported by the clinical timeline, negative blood culture (expected at this stage), and Widal serology pattern consistent with established infection. ### Why Blood Culture Is Negative at Week 3 **Key Point:** Blood culture positivity follows a predictable timeline in enteric fever: - **Week 1:** ~90% positive - **Week 2:** ~40–50% positive - **Week 3:** ~10–20% positive (as shown here) - **After Week 4:** Rarely positive At week 3, bacteria have largely shifted from bloodstream to lymphoid tissues (Peyer's patches, mesenteric lymph nodes) and bone marrow, making blood culture unreliable. ### Widal Serology Interpretation in Enteric Fever ```mermaid flowchart TD A[Widal Test Results]:::outcome --> B{Clinical Timeline?}:::decision B -->|Week 1-2<br/>Acute Illness| C[O antigen rises first<br/>H antigen follows]:::action B -->|Week 2-3<br/>Established Infection| D[Both O and H elevated<br/>ABO may appear]:::action B -->|Week 3+<br/>Recovery/Carrier| E[O antigen persists<br/>H antigen declines<br/>ABO positive]:::action C --> F[Blood culture likely positive<br/>Start empiric therapy]:::action D --> G[Blood culture may be negative<br/>Bone marrow culture if needed<br/>Continue therapy]:::action E --> H[Blood culture negative<br/>Consider carrier state<br/>Assess for complications]:::action ``` ### Widal Titre Interpretation Table | Antigen | Week 1 | Week 2 | Week 3+ | Interpretation | |---------|--------|--------|---------|----------------| | **O (Somatic)** | Rises first | Peaks | Persists longest | Most reliable; indicates acute infection | | **H (Flagellar)** | Rises later | Peaks with O | Declines faster | Supports acute infection; declines in recovery | | **ABO (Salmonella paratyphi B)** | Absent | Absent | May appear | Indicates chronic carrier or late-stage infection | **High-Yield:** The presence of ABO antigen (1:160 in this case) suggests **chronic carrier state or late-stage infection**, not acute first-episode typhoid. ### Clinical Features Consistent with Week 3 Enteric Fever **Key Point:** By week 3, the clinical picture shifts: - **Fever pattern:** May become intermittent or absent (as in this patient, who is afebrile at examination) - **GI symptoms:** Constipation more common than diarrhoea (due to Peyer's patch necrosis and ileal perforation risk) - **Hepatosplenomegaly:** Persists as bacteria localize to reticuloendothelial tissues - **Rash:** Rose spots may still be visible - **Relative lymphocytosis:** Characteristic finding throughout enteric fever **Clinical Pearl:** Absence of diarrhoea with constipation is a red flag for **ileal perforation risk**; abdominal examination must exclude peritonitis. ### Why Other Options Are Incorrect **Option 1 (Acute enteric fever with early complications):** Acute enteric fever is typically weeks 1–2 with positive blood culture. At week 3 with negative blood culture, this is established (not acute) enteric fever. **Option 3 (Chronic carrier state):** Chronic carriers are asymptomatic or minimally symptomatic; this patient has active fever and systemic symptoms. True chronic carriers have negative blood cultures but positive stool/urine cultures and ABO antigen in Widal. **Option 4 (Brucellosis):** Brucella serology (Rose-Bengal test, standard tube agglutination) is different from Widal; brucellosis does not produce O/H/ABO antigens. Cross-reactivity with Widal is rare and would not explain the full pattern here. ### Management at Week 3 **High-Yield:** At week 3 with negative blood culture but positive Widal and clinical features: 1. **Continue antibiotic therapy** (do not stop because blood culture is negative) 2. **Consider bone marrow culture** if diagnosis remains uncertain (higher sensitivity at this stage) 3. **Monitor for complications:** ileal perforation, myocarditis, encephalopathy 4. **Assess nutritional status** and begin supportive care 5. **Do NOT diagnose carrier state yet**; wait for convalescence and stool culture follow-up
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.